Examkin

Question

Difficulty: MediumGynecologic Oncology

A physician is evaluating a patient who reports intermittent pinkish spotting on her undergarments for the past 33 weeks. The patient is 5858 years of age, and her last natural menstrual period occurred 77 years ago. Her medical history is significant for well-controlled type 22 diabetes mellitus. Her current body mass index is 34 kg/m234 \text{ kg/m}^2. She takes metformin and daily low-dose aspirin. During the speculum examination, the vaginal mucosa appears pale, thinned, and lacks normal rugation. A scant amount of brownish fluid is pooled in the posterior vaginal fornix, but no active bleeding is observed. The bimanual examination shows a small, mobile uterus and no adnexal masses. Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial biopsyAnswer
  2. B
    Initiation of topical vaginal estrogen therapy
  3. C
    Discontinuation of daily low-dose aspirin
  4. D
    Measurement of serum follicle-stimulating hormone
  5. E
    Reassurance and routine follow-up in one year

Answer

Endometrial biopsy
This patient is presenting with postmenopausal bleeding, which requires prompt and definitive evaluation to rule out endometrial carcinoma. Although her physical examination reveals pale and thinned vaginal mucosa—highly suggestive of atrophic vaginitis—the presence of any bleeding in a postmenopausal woman dictates mandatory investigation of the endometrium. This is typically accomplished via an endometrial biopsy (which provides histologic diagnosis) or a transvaginal ultrasound (to evaluate endometrial thickness). Furthermore, her obesity and type 22 diabetes place her at substantially elevated risk for endometrial cancer due to unopposed estrogen stimulation.

Step-by-Step Solution

1
Identify the primary clinical problem and the patient's menopausal status.
The patient has postmenopausal bleeding (PMB), defined as any vaginal bleeding occurring >12>12 months after natural menopause.
Establishing the presence of PMB is the most critical trigger for the gynecologic oncology diagnostic pathway.
2
Assess the patient's risk factors for endometrial malignancy.
The patient is at high risk due to her age (5858 years), obesity (BMI 34 kg/m234 \text{ kg/m}^2), and type 22 diabetes mellitus.
Obesity leads to increased peripheral conversion of androgens to estrogens, causing unopposed estrogen exposure which drives endometrial hyperplasia and carcinoma.
3
Determine the standard of care for initial evaluation of PMB.
An endometrial biopsy or transvaginal ultrasound must be performed immediately.
Endometrial cancer must be definitively ruled out before any bleeding can be safely attributed to benign causes such as atrophic vaginitis or medication side effects.

Key Concept

Evaluation of Postmenopausal Bleeding
Rate this question

Topics

Gynecologic Oncology

More questions from this topic